Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I.
Curr Hematol Malig Rep. 2016 Oct;11(5):333-41. doi: 10.1007/s11899-016-0338-x.
Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
Kuo E, Kumarapeli AR.
Arch Pathol Lab Med. 2020 Mar;144(3):388-393. doi: 10.5858/arpa.2018-0248-RS. Epub 2019 Apr 10.
Neonatal Leukemia.
Brown PA.
Clin Perinatol. 2021 Mar;48(1):15-33. doi: 10.1016/j.clp.2020.11.002.
Neonatal leukaemia.
Roberts I, Fordham NJ, Rao A, Bain BJ.
Br J Haematol. 2018 Jul;182(2):170-184. doi: 10.1111/bjh.15246. Epub 2018 May 28.
Recalcitrant transient abnormal myelopoiesis in neonatal Down syndrome.
Timmis S, Hodder A, Bharadwaj N, Inglott S, Chalker J, Cheng D, Tandon S, Bartram J.
Pediatr Blood Cancer. 2022 Oct;69(10):e29662. doi: 10.1002/pbc.29662. Epub 2022 Mar 16.
Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K.
Pediatr Int. 2019 Mar;61(3):222-229. doi: 10.1111/ped.13776. Epub 2019 Mar 4.
Transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H, Hara J, Yumura-Yagi K, Tawa A, Kawa-Ha K.
Leuk Lymphoma. 1992 Dec;8(6):465-75. doi: 10.3109/10428199209051029.
Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
Bombery M, Vergilio JA.
Arch Pathol Lab Med. 2014 Oct;138(10):1302-6. doi: 10.5858/arpa.2014-0304-CC.
Down syndrome-associated transient abnormal myelopoiesis with placental involvement.
Daneshbod Y, Raghavan R.
EJHaem. 2022 Sep 20;3(4):1414-1415. doi: 10.1002/jha2.495. eCollection 2022 Nov.
Management of Down Syndrome-Associated Leukemias: A Review.
Verma A, Lupo PJ, Shah NN, Hitzler J, Rabin KR.
JAMA Oncol. 2023 Sep 1;9(9):1283-1290. doi: 10.1001/jamaoncol.2023.2163.
